Overview: Two of the Most Studied Nootropic Peptides in Research
Selank and Semax are two synthetic peptides developed in Russia that have become among the most studied nootropic and anxiolytic compounds in the peptide research space. Both are derived from endogenous peptides with established roles in the central nervous system, and both have accumulated substantial research literature on their cognitive, anxiolytic, and neuroprotective properties. While distinct in their mechanisms and primary applications, they are frequently studied together as complementary tools for investigating different aspects of neurological function.
Selank: The Synthetic Anxiolytic Heptapeptide
What Is Selank?
Selank is a synthetic heptapeptide (seven amino acids) derived from the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with the addition of a Pro-Gly-Pro sequence that significantly extends its stability and biological activity. Its full sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, with a molecular weight of approximately 751.9 Da.
Originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank was designed to replicate and extend the anxiolytic properties of tuftsin while improving metabolic stability. It has been studied extensively for its effects on anxiety, stress response, cognitive function, and immune modulation.
Selank Mechanism of Action
Selank’s mechanism is multifaceted and not fully elucidated, which is part of what makes it an interesting research compound. Its primary known mechanisms include:
GABAergic Modulation — Selank appears to influence GABA-A receptor function, which is consistent with its anxiolytic profile. The GABAergic system is the primary inhibitory neurotransmitter system in the CNS and the target of classical anxiolytic compounds. However, Selank’s mechanism at this receptor appears distinct from benzodiazepines, suggesting a different binding site or modulatory mechanism.
BDNF Upregulation — Research has demonstrated that Selank increases expression of brain-derived neurotrophic factor (BDNF) — a key neurotrophin involved in neuronal survival, synaptic plasticity, and cognitive function. BDNF upregulation is associated with improved learning, memory consolidation, and neuroprotection.
Enkephalin Stabilization — Selank inhibits enkephalin-degrading enzymes, increasing the availability of endogenous enkephalins — endogenous opioid peptides involved in pain modulation, stress response, and mood regulation.
Serotonin System Modulation — Research has investigated Selank’s effects on serotonergic transmission, with studies suggesting it influences serotonin metabolism and receptor sensitivity in ways that may contribute to its anxiolytic and mood-stabilizing effects.
Immune System Interaction — As a tuftsin derivative, Selank retains some of the immunomodulatory properties of its parent peptide. Research has examined its effects on cytokine expression, T-cell activity, and innate immune function.
Selank Research Applications
Anxiety and Stress Research — Selank’s most established research application concerns anxiety and stress response. Studies in animal models have demonstrated anxiolytic effects comparable to classical anxiolytic compounds without the sedation, dependence, or cognitive impairment associated with benzodiazepines. Research has examined its effects on stress-induced behavioral changes, anxiety-related behaviors in elevated plus maze and open field tests, and corticosterone stress response markers.
Cognitive and Memory Research — Research has investigated Selank’s effects on learning and memory consolidation, attention, and cognitive performance under stress conditions. The BDNF-upregulating mechanism makes it particularly relevant for research on stress-impaired cognition and neuroplasticity.
Immunological Research — Selank’s tuftsin-derived structure gives it immunomodulatory properties that have been studied in inflammatory and immune regulation models. Research has examined its effects on cytokine profiles, natural killer cell activity, and immune response under stress.
Semax: The ACTH-Derived Neuropeptide
What Is Semax?
Semax is a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-7) with the addition of a Pro-Gly-Pro sequence — the same C-terminal extension used in Selank. Its sequence is Met-Glu-His-Phe-Pro-Gly-Pro, with a molecular weight of approximately 887.0 Da.
Developed alongside Selank at the Institute of Molecular Genetics, Semax was designed to replicate the cognitive-enhancing properties of ACTH fragments while eliminating the adrenal-stimulating and steroidogenic effects of the parent hormone. Like Selank, the Pro-Gly-Pro extension significantly improves metabolic stability compared to the unmodified ACTH fragment.
Semax Mechanism of Action
Semax operates through several distinct mechanisms that collectively produce its nootropic and neuroprotective profile:
BDNF and NGF Upregulation — Semax’s most well-documented mechanism is the robust upregulation of both BDNF and nerve growth factor (NGF) in hippocampal and cortical tissues. This neurotrophic factor upregulation is believed to underlie many of its cognitive-enhancing and neuroprotective effects, as BDNF and NGF are critical for neuronal survival, synaptic strengthening, and long-term potentiation.
Dopaminergic and Serotonergic Modulation — Research has demonstrated that Semax influences dopamine and serotonin metabolism in the prefrontal cortex and limbic system — regions critical for working memory, attention, motivation, and mood regulation.
Melanocortin Receptor Interaction — As an ACTH derivative, Semax interacts with melanocortin receptors (particularly MC4R) in the brain, which are involved in cognitive function, energy balance, and neuroprotection.
Anti-inflammatory CNS Effects — Research has investigated Semax’s effects on neuroinflammation, particularly its ability to reduce expression of pro-inflammatory cytokines in brain tissue and protect against inflammation-induced neuronal damage.
Nitric Oxide Pathway Modulation — Studies have examined Semax’s influence on nitric oxide synthase expression in brain tissue, with implications for cerebrovascular research and neuroprotection models.
Semax Research Applications
Cognitive Enhancement Research — Semax is one of the most studied peptides for cognitive enhancement mechanisms. Research has examined its effects on working memory, attention span, learning rate, and memory consolidation in both normal and cognitively impaired animal models. The robust BDNF upregulation makes it particularly relevant for research on neuroplasticity and cognitive aging.
Neuroprotection Research — Semax has been extensively studied in models of ischemic brain injury, oxidative stress-induced neuronal damage, and neurodegeneration. Research has examined its ability to reduce infarct size in stroke models, protect against excitotoxic neuronal death, and preserve cognitive function following neurological insult.
Attention and Focus Research — The dopaminergic and noradrenergic effects of Semax in prefrontal cortical circuits have led to research into its effects on attention, executive function, and working memory — cognitive domains heavily dependent on catecholaminergic signaling in the prefrontal cortex.
Mood and Depression Research — Research has investigated Semax in models of depression and anhedonia, examining its effects on reward circuitry, serotonergic transmission, and behavioral indicators of depressive states in animal models.
Selank vs Semax: Complementary Research Tools
While both peptides share structural similarities (the Pro-Gly-Pro C-terminal extension) and both upregulate BDNF, they have distinct primary mechanisms and research applications that make them complementary rather than redundant:
- Selank — primarily anxiolytic, GABAergic modulation, tuftsin-derived immunomodulatory properties, stress response research
- Semax — primarily nootropic and neuroprotective, ACTH-derived melanocortin receptor interaction, stronger BDNF/NGF upregulation, cognitive enhancement and ischemia research
Research designs frequently use both compounds in parallel arms to distinguish GABAergic anxiolytic mechanisms (Selank) from neurotrophic cognitive-enhancing mechanisms (Semax) in behavioral and neurochemical studies.
Related Research Compounds at AminoForge
Researchers studying nootropic peptide mechanisms may also be interested in Dihexa — a potent HGF/MET pathway activator studied for synaptic plasticity — and Pinealon, a tripeptide bioregulator with neuroprotective properties. For sleep and stress axis research, DSIP (Delta Sleep Inducing Peptide) offers a complementary research tool targeting the stress-sleep interface.
Shop Selank and Semax at AminoForge — ≥99% purity, third-party COA verified, USA manufactured, ships within 48 hours.
Formulation and Storage
Both Selank and Semax are available as lyophilized powders. Both are relatively stable compared to larger peptides but should be stored at -20°C in lyophilized form. Reconstituted solutions should be kept at 2–8°C and protected from light. Bacteriostatic water is the standard reconstitution vehicle for both compounds.
Selank: molecular weight ~751.9 Da. Semax: molecular weight ~887.0 Da. Research-grade purity should be verified at ≥99% by HPLC for both compounds.
Selank anxiolytic mechanism research
All products sold by AminoForge are intended exclusively for laboratory and research purposes. Not for human or veterinary consumption. Researchers are responsible for compliance with all applicable laws and regulations governing research compound use in their jurisdiction.